WASHINGTON — Reaching for a cigarette to cope with a flashback is all too common among sufferers of post-traumatic stress disorder. The nicotine hit may feel good but scientists say its brain action ...

Could a marijuana-based medicine potentially prevent the symptoms of post-traumatic stress disorder (PTSD)? If the findings of a new study in rodents hold up, they may offer a new avenue for treatment ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

A promising new drug could help people living with post-traumatic stress disorder (PTSD) finally let go of trauma. This is the discovery of scientists at the Institute of Basic Science (IBS) and Ewha ...

When I entered rehab at 23, I learned that trauma was a thread woven into most addiction stories. Many people in my program described horrific neglect or maltreatment, including sexual abuse, they had ...

The US Food and Drug Administration has rejected a first-of-its-kind proposal to use the psychedelic drug MDMA, also known as ecstasy or Molly, as a treatment for post-traumatic stress disorder.

WASHINGTON -- Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind ...

A growing body of evidence points to MDMA's therapeutic potential for managing an array of hard-to-treat conditions like PTSD and depression. Antonio Ciufo/Moment via Getty Images MDMA, or ...

The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans ...

WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...

U.S FDA has accepted IND application for COMP360 in PTSD, enabling the initiation of a Phase 2b/3 (COMP202) clinical trial in patients living with PTSD.